| Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT (NCT05696457) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2021-02-01 |
| Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 (NCT04452604) | French Innovative Leukemia Organisation | 2020-09-11 |
| Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia (NCT04082286) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2016-05-01 |
| Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia (NCT01966497) | Assistance Publique - Hôpitaux de Paris | 2012-11-01 |
| Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia (NCT01435343) | PETHEMA Foundation | 2012-07-01 |
| Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia (NCT01611116) | Goethe University | 2012-05-01 |
| Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft (NCT03280290) | University Hospital, Lille | 2012-03-20 |
| Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (NCT01457885) | University of Michigan Rogel Cancer Center | 2011-11-01 |
| RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML (NCT01307241) | National Institute of Cancerología | 2010-12-01 |
| PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years (NCT01296178) | PETHEMA Foundation | 2010-12-01 |
| LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) (NCT01041040) | PETHEMA Foundation | 2007-10-01 |
| Natural Killer Index From Hematopoietic Stem Cell Graft (NCT00435864) | Nantes University Hospital | 2007-04-01 |
| Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children (NCT00552825) | Sheba Medical Center | 2005-10-01 |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (NCT00354120) | Gruppo Italiano Trapianto di Midollo Osseo | 2005-03-01 |
| Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients (NCT00504920) | M.D. Anderson Cancer Center | 2004-05-01 |
| Treatment of Acute Myeloblastic Leukemia in Younger Patients (NCT00390715) | PETHEMA Foundation | 1999-01-01 |
| SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia (NCT00487448) | PETHEMA Foundation | 1998-07-01 |